The 20 Most-Read Articles in March 2021
Of articles published within the last 12 months, based on full-text and pdf views.
- Antibody Responses to SARS-CoV-2: Lets Stick to Known Knowns
Nicole Baumgarth, Janko Nikolich-Žugich, F. Eun-Hyung Lee and Deepta Bhattacharya
J Immunol Nov 01, 2020; 205: 2342-2350. - COVID-19 as an Acute Inflammatory Disease
Rose H. Manjili, Melika Zarei, Mehran Habibi and Masoud H. Manjili
J Immunol Jul 01, 2020; 205: 12-19. - Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19
Jeremy K. Y. Yap, Miyu Moriyama and Akiko Iwasaki
J Immunol Jul 15, 2020; 205: 307-312. - Early Insights into Immune Responses during COVID-19
Ashley L. St. John and Abhay P. S. Rathore
J Immunol Aug 01, 2020; 205: 555-564. - A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
Wafaa B. Alsoussi, Jackson S. Turner, James B. Case, Haiyan Zhao, Aaron J. Schmitz, Julian Q. Zhou, Rita E. Chen, Tingting Lei, Amena A. Rizk, Katherine M. McIntire, Emma S. Winkler, Julie M. Fox, Natasha M. Kafai, Larissa B. Thackray, Ahmed O. Hassan, Fatima Amanat, Florian Krammer, Corey T. Watson, Steven H. Kleinstein, Daved H. Fremont, Michael S. Diamond and Ali H. Ellebedy
J Immunol Aug 15, 2020; 205: 915-922. - COVID-19: Complement, Coagulation, and Collateral Damage
Martin W. Lo, Claudia Kemper and Trent M. Woodruff
J Immunol Sep 15, 2020; 205: 1488-1495. - Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19
Judy Chen, William J. Kelley and Daniel R. Goldstein
J Immunol Jul 15, 2020; 205: 313-320. - A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections
Marika Orlov, Pandora L. Wander, Eric D. Morrell, Carmen Mikacenic and Mark M. Wurfel
J Immunol Aug 15, 2020; 205: 892-898. - Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients
Renata Varnaitė, Marina García, Hedvig Glans, Kimia T. Maleki, John Tyler Sandberg, Janne Tynell, Wanda Christ, Nina Lagerqvist, Hilmir Asgeirsson, Hans-Gustaf Ljunggren, Gustaf Ahlén, Lars Frelin, Matti Sällberg, Kim Blom, Jonas Klingström and Sara Gredmark-Russ
J Immunol Nov 01, 2020; 205: 2437-2446.
10. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm
Alexandre E. Nowill and Pedro O. de Campos-Lima
J Immunol Nov 15, 2020; 205: 2566-2575.
11. Novel SIRPα Antibodies That Induce Single-Agent Phagocytosis of Tumor Cells while Preserving T Cells
Gabriela Andrejeva, Benjamin J. Capoccia, Ronald R. Hiebsch, Michael J. Donio, Isra M. Darwech, Robyn J. Puro and Daniel S. Pereira
J Immunol Feb 15, 2021; 206: 712-721.
12. IFN-Stimulated Gene 15 Is an Alarmin that Boosts the CTL Response via an Innate, NK Cell-Dependent Route
Victoria Iglesias-Guimarais, Tomasz Ahrends, Evert de Vries, Klaus-Peter Knobeloch, Andriy Volkov and Jannie Borst
J Immunol Apr 15, 2020; 204: 2110-2121.
13. Neonatal and Children's Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy
Shokrollah Elahi
J Immunol Oct 15, 2020; 205: 1990-1997.
14. SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals
Pedro Martínez-Fleta, Arantzazu Alfranca, Isidoro González-Álvaro, Jose M. Casasnovas, Daniel Fernández-Soto, Gloria Esteso, Yaiza Cáceres-Martell, Sofía Gardeta, Celia López-Sanz, Salomé Prat, Tamara Mateu-Albero, Ligia Gabrie, Eduardo López-Granados, Francisco Sánchez-Madrid, Hugh T. Reyburn, José M. Rodríguez Frade and Mar Valés-Gómez
J Immunol Dec 01, 2020; 205: 3130-3140.
15. Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators
Benjamin Schwarz, Lokesh Sharma, Lydia Roberts, Xiaohua Peng, Santos Bermejo, Ian Leighton, Arnau Casanovas-Massana, Maksym Minasyan, Shelli Farhadian, Albert I. Ko, Yale IMPACT Team, Charles S. Dela Cruz and Catharine M. Bosio
J Immunol Jan 15, 2021; 206: 329-334.
16. SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals
Cecilie Bo Hansen, Ida Jarlhelt, Laura Pérez-Alós, Lone Hummelshøj Landsy, Mette Loftager, Anne Rosbjerg, Charlotte Helgstrand, Jais Rose Bjelke, Thomas Egebjerg, Joseph G. Jardine, Charlotte Sværke Jørgensen, Kasper Iversen, Rafael Bayarri-Olmos, Peter Garred and Mikkel-Ole Skjoedt
J Immunol Jan 01, 2021; 206: 109-117.
17. SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production
Rafael Franco, Rafael Rivas-Santisteban, Joan Serrano-Marín, Ana I. Rodríguez-Pérez, José L. Labandeira-García and Gemma Navarro
J Immunol Sep 01, 2020; 205: 1198-1206.
18. Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile
Jaclyn C. Law, Wan Hon Koh, Patrick Budylowski, Jonah Lin, FengYun Yue, Kento T. Abe, Bhavisha Rathod, Melanie Girard, Zhijie Li, James M. Rini, Samira Mubareka, Allison McGeer, Adrienne K. Chan, Anne-Claude Gingras, Tania H. Watts and Mario A. Ostrowski
J Immunol Jan 01, 2021; 206: 37-50.
19. Systematic Profiling of Full-Length Ig and TCR Repertoire Diversity in Rhesus Macaque through Long Read Transcriptome Sequencing
Hayden N. Brochu, Elizabeth Tseng, Elise Smith, Matthew J. Thomas, Aiden M. Jones, Kayleigh R. Diveley, Lynn Law, Scott G. Hansen, Louis J. Picker, Michael Gale Jr. and Xinxia Peng
J Immunol Jun 15, 2020; 204: 3434-3444.
20. Malat1 Suppresses Immunity to Infection through Promoting Expression of Maf and IL-10 in Th Cells
James P. Hewitson, Katie A. West, Kylie R. James, Gulab Fatima Rani, Nidhi Dey, Audrey Romano, Najmeeyah Brown, Sarah A. Teichmann, Paul M. Kaye and Dimitris Lagos
J Immunol Jun 01, 2020; 204: 2949-2960.
